HubSpot
HUBS
$231.98
+6.78%
HubSpot operates a cloud-based customer relationship management platform spanning marketing, sales, service, content management, and operations hubs, sold à la carte or bundled to small and mid-market businesses globally. The company is a recognized category leader in inbound marketing and mid-market CRM, positioned as the approachable, integrated alternative to Salesforce and Microsoft Dynamics for scaling companies rather than a pure enterprise disruptor. The current investor narrative is dominated by a painful growth-to-profitability transition: after years of premium-multiple expansion, the stock has de-rated sharply as decelerating customer growth and seat-based pricing pressure collide with an AI-driven rotation that has favored infrastructure names over application software. Management's aggressive pivot toward margin expansion and free cash flow — evidenced by a dramatic swing from quarterly losses in early 2025 to solid profitability in 2026, alongside a large buyback program — is the central bull case, while bears point to slowing top-line growth, elevated stock-based compensation, and the risk that AI agents disintermediate traditional marketing and sales workflows.…
HUBS
HubSpot
$231.98
Related headlines
Investment Opinion: Should I buy HUBS Today?
Rating: Hold. HubSpot is a high-quality, cash-generative SaaS franchise trading at a genuinely cheap 12.95x forward PE and 6.72x PS after an ~87% multiple compression from its 50.71x PS peak, but with revenue growth decelerating to 17.05%, a 'hold' consensus (8 Buy / 25 Hold / 2 Sell) and an average target of $228.90 implying only +5.4% upside from $217.25, there is no catalyst yet to justify chasing the stock. The core thesis is that the profitability inflection — Q3 2026 net income of $82.97 million versus a -$3.26 million loss in Q2 2025 — and $773.53 million of trailing free cash flow provide a valuation floor, while the absence of stabilizing customer growth caps the upside.
Supporting evidence is strong on cash and margins but weak on momentum: the 82.62% gross margin and $183.30 million of Q3 free cash flow imply an FCF yield near 3.7% on the ~$21.05 billion market cap; the PEG of 0.52 and 2.66x EV/Sales sit at or below mature high-teens-growth software peers; the balance sheet is a fortress with 0.127 debt-to-equity, a 1.67 current ratio and $1.12 billion of cash; and management repurchased $767 million of stock across Q2–Q3 funded by operating cash flow of $238.03 million in Q3 alone. Against that, trailing operating margin is just 0.36%, stock-based compensation of $127.12 million per quarter offsets much of the buyback, and the stock is down 44.38% over twelve months versus the S&P 500's +12.27%.
The biggest risks that could invalidate the thesis are a further deceleration in net customer additions below mid-teens revenue growth, forward EPS of $24.41 being cut (which would instantly make the 12.95x forward PE look expensive), and the AI-agent narrative continuing to disintermediate marketing and sales workflows. This Hold would upgrade to Buy if net customer additions stabilize and revenue growth holds at or above 17% with operating margin sustained above 7%, or if the stock retests the $170 area with fundamentals intact; it would downgrade to Sell if revenue growth falls below 15% or forward EPS estimates are revised down materially. Verdict: fairly valued to modestly undervalued relative to its own history and peers, but not yet a compelling buy — a show-me turnaround.
Sign up to view all
HUBS 12-Month Price Forecast
HubSpot presents a fairly valued, show-me turnaround: the valuation is genuinely cheap at 12.95x forward earnings and 6.72x sales after an ~87% compression from peak multiples, and the profitability inflection plus $773.53 million of trailing free cash flow provide a real floor. But the evidence for a durable re-rating is not yet in place — revenue growth is decelerating to 17.05%, the sell-side consensus is a hold with only +5.4% implied upside, and three brokerages downgraded in early November. The stock's 44.38% twelve-month decline and -56.65 point relative-strength gap reflect a violent rotation out of application software that will not reverse on valuation alone. I would upgrade to bullish if net customer additions stabilize and AI becomes a monetization tailwind rather than a threat; I would downgrade to bearish if revenue growth falls below 15% or forward EPS estimates are cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on HubSpot's 12-month outlook, with a consensus price target around $228.90 and implied upside of -1.3% versus the current price.
Average Target
$228.90
35 analysts
Implied Upside
-1.3%
vs. current price
Analyst Count
35
covering this stock
Price Range
$170 - $320
Analyst target range
Coverage is broad but decidedly cautious: 28 analysts cover HubSpot with a distribution of 8 Buy, 25 Hold, and 2 Sell, yielding a consensus recommendation of "hold" and a recommendation mean of 2.69 (where 3.0 is a pure hold). The average target price of $228.90 implies roughly +5.4% upside from the current $217.25 — a modest, neutral signal that suggests the Street sees the stock as fairly valued after its collapse rather than deeply mispriced. The consensus leans neutral-to-bearish, consistent with the post-Q3 wave of cautious actions.
The target range of $170.00 to $320.00 is wide — the high target is 88% above the low — signaling genuine disagreement about the growth trajectory. The $320 high case likely assumes growth reaccelerates toward 20%+, margin expansion continues, and the AI narrative turns from threat to tailwind (e.g., AI-powered agents driving seat expansion and upsells). The $170 low target, essentially at the 52-week low, prices in continued customer-growth deceleration, competitive pressure from AI-native tools, and multiple compression toward a low-growth software profile. Recent institutional actions skew negative: in the November 5–6 window, KeyBanc downgraded to Sector Weight from Overweight, BTIG cut to Neutral from Buy, and Cantor Fitzgerald moved to Underweight from Neutral, while Truist maintained Buy and Citi, UBS, Piper Sandler, Wells Fargo, Barclays, and JPMorgan stayed neutral. That pattern — more downgrades than upgrades, with the bulls thinning — reinforces the hold consensus and suggests the stock needs a fundamental catalyst (stabilizing net customer additions or a credible AI monetization story) before the sell-side turns constructive.
Bulls vs Bears: HUBS Investment Factors
The bear case currently carries slightly stronger near-term evidence: revenue growth is decelerating to 17.05%, the sell-side consensus is a 'hold' with only +5.4% implied upside, three brokerages downgraded in early November, and the stock remains in a pronounced downtrend with a -56.65 point one-year relative-strength gap. However, the bull case is genuinely compelling on valuation and cash generation — a 12.95x forward PE, 0.52 PEG, 6.72x PS, $773.53 million of trailing FCF, an 82.62% gross margin, and a dramatic swing to $82.97 million of Q3 net income suggest much of the bad news is priced in. The single most important tension is whether the margin-expansion and FCF story can hold while growth stabilizes in the high-teens; if net customer additions stabilize and AI becomes a monetization tailwind rather than a threat, the multiple has enormous room to re-rate, but if growth decelerates below mid-teens the 'value trap' read wins. Net, this is a fairly valued, show-me turnaround where the risk/reward is improving but the catalyst for a durable re-rating has not yet arrived.
Bullish
- Dramatic profitability inflection: Q3 2026 net income hit $82.97 million (8.76% net margin), a sharp reversal from the -$3.26 million loss in Q2 2025 and -$21.79 million loss in Q1 2025. Quarterly operating income has climbed sequentially from $29.04 million in Q1 to $43.32 million in Q2 to $71.89 million in Q3, showing real operating leverage emerging.
- Cheap on forward earnings and sales: The forward PE of 12.95x on consensus EPS of $24.41 is a steep discount to the 25–35x forward range typical of application software, and the PEG of 0.52 implies the stock is cheap relative to expected growth. At 6.72x PS and 2.66x EV/Sales, HubSpot trades at or below mature high-teens-growth software peers after an ~87% compression from its 50.71x PS peak at year-end 2024.
- Strong free cash flow and buybacks: Trailing free cash flow of $773.53 million against a ~$21.05 billion market cap implies an FCF yield near 3.7%, with Q3 FCF of $183.30 million. Management repurchased $230.81 million of stock in Q3 and $536.20 million in Q2, funded by operating cash flow of $238.03 million rather than debt, signaling confidence at depressed prices.
- Best-in-class gross margins: Gross margin remains 82.62% (gross profit of $782.89 million on $947.57 million revenue), consistent with the 82–84% band held for years and typical of premium SaaS economics. This high-margin recurring base (subscription revenue of $930.24 million of the $947.57 million total) supports the margin-expansion thesis.
Bearish
- Decelerating revenue growth: Q3 2026 revenue grew 17.05% year-over-year to $947.57 million, down from the ~19% pace implied by the prior-year comparison, and the consensus $5.45 billion estimate implies further deceleration to ~16–17%. The sequential cadence ($880.99M to $911.74M to $947.57M) shows steady dollar expansion but a clear normalization toward high-teens growth.
- Sell-side has turned cautious: Of 28 analysts, only 8 rate Buy versus 25 Hold and 2 Sell, yielding a consensus 'hold' and recommendation mean of 2.69. The average target of $228.90 implies just +5.4% upside from $217.25, and the November 5–6 window brought downgrades from KeyBanc, BTIG, and Cantor Fitzgerald — more downgrades than upgrades.
- Thin operating margins: Trailing operating margin is only 0.36%, and even the strong Q3 quarter delivered just a 7.59% operating margin, burdened by $401.61 million of sales and marketing and $223.28 million of R&D. The gap between the 82.62% gross margin and low single-digit operating margin is the core debate — sustained profitability requires continued cost discipline.
- Stock-based compensation dilution: Stock-based compensation of $127.12 million in Q3 remains a real dilution offset against the buyback program, and shares outstanding have only drifted from 52.67 million (Q3 2025) to 49.47 million (Q3 2026) despite $767 million of repurchases across Q2–Q3. Elevated SBC continues to weigh on true shareholder returns.
HUBS Technical Analysis
HubSpot is locked in a pronounced, year-long downtrend that has only recently begun to stabilize. The stock is down 44.38% over the trailing twelve months and 43.16% year-to-date, a staggering underperformance versus the S&P 500's +12.27% one-year return, producing a relative strength gap of -56.65 percentage points. At $217.25, the shares sit roughly 53% of the way up the 52-week range of $169.63 to $406.94 — closer to the floor than the ceiling — and the -65.57% max drawdown underscores how violent the de-rating has been. This positioning is neither a clean momentum trade nor a deep-value falling knife; it is a broken former high-flyer attempting to carve a base well below its highs.
Short-term momentum is mixed and diverging from the longer arc. The stock is down 3.97% over the past month and 3.07% over three months, both modestly worse than the S&P 500's -2.26% and -2.83% respectively, yielding relative strength readings of -1.71 (1-month) and -0.24 (3-month). Yet the six-month change is +9.51%, a full 7.38 points of outperformance versus the index, revealing that the stock bottomed in the spring and staged a meaningful recovery into the autumn before rolling over again. The recent sequence is telling: a rally to $270.88 on October 23 has given way to a slide to $217.25, a roughly 20% pullback in three weeks, with the November 4 Q3 print acting as the catalyst. The stock's beta of 1.141 means it amplifies market moves by about 14%, so this whipsaw is consistent with a high-sensitivity name in a choppy tape.
Key technical levels are well defined. Support rests at the 52-week low of $169.63, roughly 22% below the current price; a breakdown there would signal a resumption of the primary downtrend and likely force another leg of institutional selling. Resistance sits at the 52-week high of $406.94, an 87% gap above spot that is unlikely to be challenged without a fundamental re-rating, with intermediate resistance around the October high of $270.88. The wide $169.63–$406.94 band and the -65.57% drawdown confirm an exceptionally volatile profile; with a beta of 1.141 and a short ratio of 3.01, position sizing should account for the real risk of another 20%+ swing in either direction around catalysts.
Beta
1.14
1.14x market volatility
Max Drawdown
-65.6%
Largest decline past year
52-Week Range
$170-$407
Price range past year
Annual Return
-41.5%
Cumulative gain past year
| Period | HUBS Return | S&P 500 |
|---|---|---|
| 1m | +0.5% | -3.0% |
| 3m | +2.5% | -3.6% |
| 6m | +14.1% | -0.2% |
| 1y | -41.5% | +10.1% |
| ytd | -39.3% | +8.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HUBS Fundamental Analysis
HubSpot's revenue trajectory remains solid but is clearly decelerating. Q3 2026 revenue came in at $947.57 million, up 17.05% year-over-year, a healthy absolute growth rate but a step down from the ~19% pace implied by the prior-year comparison (Q3 2025 revenue of $809.52 million versus Q3 2024's roughly $680 million). The sequential cadence tells the story: revenue climbed from $880.99 million in Q1 to $911.74 million in Q2 to $947.57 million in Q3, steady dollar expansion but with growth normalizing toward the high-teens. Subscription revenue of $930.24 million dwarfs the $17.32 million service line, meaning essentially the entire franchise rides on recurring software seats — a high-quality but concentrated model that is directly exposed to the customer-growth slowdown that triggered the August selloff. The consensus revenue estimate of $5.45 billion implies roughly 16–17% forward growth, confirming the market expects continued deceleration rather than reacceleration.
Profitability has inflected dramatically and is the strongest part of the story. Q3 2026 net income reached $82.97 million on a net margin of 8.76%, a massive improvement from the -$3.26 million loss in Q2 2025 and the -$21.79 million loss in Q1 2025. Gross margin remains best-in-class at 82.62% (gross profit of $782.89 million), consistent with the 82–84% band the company has held for years and typical of premium SaaS economics. Operating margin, however, is thin at just 0.36% on a trailing basis (Q3 operating income of $71.89 million, a 7.59% quarterly operating margin), reflecting the heavy burden of sales and marketing ($401.61 million) and R&D ($223.28 million). The gap between the 82.62% gross margin and the low single-digit operating margin is the entire bull-bear debate: the company has proven it can flip to profit, but doing so sustainably requires either operating leverage or continued cost discipline.
Balance sheet and cash generation are genuinely strong and underpin the contrarian case. Free cash flow is robust — $773.53 million on a trailing basis and $183.30 million in Q3 alone — against a market cap of roughly $21.05 billion, implying an FCF yield near 3.7%. The debt-to-equity ratio is a conservative 0.127, the current ratio is a healthy 1.67, and cash stood at $1.12 billion at quarter-end. ROE is modest at 2.22% and ROA at 3.52%, reflecting the still-recent return to profitability, but the company is self-funding: Q3 operating cash flow of $238.03 million comfortably covered $54.72 million of capex. Management is aggressively returning capital, repurchasing $230.81 million of stock in Q3 and $536.20 million in Q2, funded by cash flow rather than debt — a signal of confidence, though stock-based compensation of $127.12 million in the quarter remains a real dilution offset that investors should monitor.
Quarterly Revenue
$947565000.0B
2026-09
Revenue YoY Growth
+17.1%
YoY Comparison
Gross Margin
82.6%
Latest Quarter
Free Cash Flow
$773526000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HUBS Overvalued?
Because HubSpot is now solidly profitable (Q3 net income of $82.97 million), the PE ratio is the appropriate primary metric, though it must be handled carefully. The trailing PE of 456.0x is distorted by a trailing-twelve-month earnings base that still absorbs the 2025 loss quarters, while the forward PE of 12.95x — based on consensus EPS of $24.41 — paints a radically different picture. That enormous gap between trailing and forward multiples signals the market expects a step-change in earnings power, and the PEG ratio of 0.52 suggests the stock is cheap relative to its expected growth if those forward estimates are achieved. The more sober read comes from EV/Sales of 2.66x and a PS ratio of 6.72x, which frame HubSpot as a mid-single-digit sales multiple software name rather than the 20x+ sales darling it once was.
Against software peers, the picture is bifurcated. On sales, HubSpot's 6.72x PS and 2.66x EV/Sales are now at or below the multiples typical of mature application-software companies growing in the high-teens, a marked discount to the 10–15x sales commanded by premium SaaS names with similar growth. On earnings, the 456x trailing PE looks absurd, but the 12.95x forward PE is a steep discount to the broader software sector, which generally trades in the 25–35x forward earnings range — implying the market is either skeptical of the consensus EPS estimate or pricing in significant risk. The 10.19x price-to-book and 27.67x price-to-cash-flow are less informative for an asset-light software business, but the 98.87x EV/EBITDA confirms that on an operating-profit basis the stock is not cheap; the cheapness is entirely a function of expected earnings acceleration.
Historically, HubSpot has never been this inexpensive on sales. Its PS ratio has collapsed from 50.71x at year-end 2024 and 41.72x in Q1 2025 to 10.70x in Q3 2026 and 6.72x today — a roughly 87% compression from peak multiples. The PE history is noisy given the loss years, but the pattern is unambiguous: the market has repriced HubSpot from a hyper-growth premium to a value-ish growth multiple. Whether this is a value opportunity or a value trap hinges on whether the 17% growth rate and margin expansion hold; at 6.72x sales with 82.62% gross margins and $773.53 million of trailing FCF, the downside appears increasingly priced in, but the stock will not re-rate until growth stabilizes.
PE
456.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 31x~1742x
vs. Industry Avg
31.1x
Industry PE ~31.1x*
EV/EBITDA
98.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the durability of the profitability inflection and the growth deceleration feeding it. Q3 2026 net income of $82.97 million and a 7.59% quarterly operating margin were achieved on 17.05% revenue growth that is decelerating from ~19%, and trailing operating margin is only 0.36% — meaning any slowdown in the top line could quickly erase the thin operating cushion given $401.61 million of quarterly sales and marketing spend. Revenue is highly concentrated in subscription seats ($930.24 million of $947.57 million), directly exposing the model to the customer-growth slowdown that triggered the August selloff, and stock-based compensation of $127.12 million per quarter remains a persistent dilution offset despite $767 million of buybacks across Q2–Q3. The balance sheet is a strength (debt-to-equity 0.127, current ratio 1.67, $1.12 billion cash), so the financial risk is earnings volatility and growth dependence rather than solvency.
Market and competitive risks are substantial given the stock's de-rating and sector dynamics. The shares carry a beta of 1.141, amplifying market moves by ~14%, and have fallen 44.38% over twelve months versus the S&P 500's +12.27% — a -56.65 point relative-strength gap that reflects a violent rotation out of application software into AI infrastructure names. Valuation compression risk cuts both ways: at 6.72x PS the stock is already ~87% below its 50.71x peak, but the 98.87x EV/EBITDA shows it is not cheap on operating profit, and the 12.95x forward PE depends entirely on consensus EPS of $24.41 being achieved. Competitive threats include AI-native tools and agents potentially disintermediating traditional marketing and sales workflows, plus pressure from Salesforce and Microsoft Dynamics in mid-market CRM; the November 5–6 downgrades from KeyBanc, BTIG, and Cantor Fitzgerald show the sell-side is pricing these risks in.
The worst-case scenario is a chain in which net customer additions keep decelerating, forward EPS estimates of $24.41 get cut, and the AI narrative remains a threat rather than a tailwind — forcing another leg of multiple compression toward a low-growth software profile. In that scenario the stock would retest its 52-week low of $169.63, roughly 22% below the current $217.25, consistent with the analyst low target of $170.00; a break below that level would signal resumption of the primary downtrend and likely trigger further institutional selling. Given the -65.57% max drawdown and the wide $169.63–$406.94 range, an investor could realistically lose 20–25% from here in an adverse outcome, and the beta of 1.141 plus a short ratio of 3.01 means another 20%+ swing in either direction around catalysts is entirely plausible.
FAQ
The most severe risk is growth deceleration: revenue grew 17.05% in Q3 2026 and the consensus $5.45 billion estimate implies further normalization to ~16–17%, so a break below 15% would undermine the entire re-rating thesis and likely push the stock toward its $169.63 low. Second is earnings-estimate risk — the 12.95x forward PE depends entirely on $24.41 of consensus EPS, and any downward revision would instantly make the stock optically expensive given the 98.87x EV/EBITDA on operating profit. Third is competitive and technological disruption, as AI-native tools and agents could disintermediate traditional marketing and sales workflows, a threat reinforced by the broader rotation out of application software (HUBS is down 44.38% over twelve months versus the S&P 500's +12.27%). Fourth is company-specific execution risk around thin margins: trailing operating margin is just 0.36%, and $127.12 million of quarterly stock-based compensation offsets much of the $767 million buyback, so the profitability inflection is not yet proven durable.
The 12-month forecast splits into three scenarios. The base case (50% probability) targets $215–$245, assuming revenue grows ~16–17% to the $5.45 billion consensus, forward EPS of $24.41 is broadly achieved, and the stock tracks the $228.90 average analyst target. The bull case (25% probability) targets $270–$320, requiring net customer additions to stabilize, AI to become a monetization tailwind, and operating margin to hold above 7% as the multiple re-rates toward 15–18x forward EPS. The bear case (25% probability) targets $170–$190, driven by growth falling below 15%, forward EPS cuts, and continued rotation out of application software, retesting the $169.63 52-week low. The base case is most likely, and its key assumption is that the profitability inflection holds while growth merely normalizes rather than collapses — a show-me outcome that leaves the stock range-bound near current levels.
On the metrics that matter for a now-profitable SaaS company, HUBS looks modestly undervalued relative to its own history and peers. The 12.95x forward PE on consensus EPS of $24.41 is a steep discount to the 25–35x forward range typical of application software, and the 6.72x PS and 2.66x EV/Sales sit at or below mature high-teens-growth peers — a roughly 87% compression from the 50.71x PS peak at year-end 2024. The trailing PE of 456x and EV/EBITDA of 98.87x look alarming but are distorted by a trailing earnings base that still absorbs the 2025 loss quarters. The catch is that the cheapness is entirely a function of expected earnings acceleration: the market is pricing in skepticism that the $24.41 forward EPS and high-teens growth will be delivered. If those estimates hold, the stock is undervalued; if they are cut, the apparent discount disappears.
From a risk/reward perspective, HUBS offers an asymmetric but unconfirmed setup. The average analyst target of $228.90 implies only +5.4% upside from $217.25, and the consensus is a hold (8 Buy / 25 Hold / 2 Sell), so the Street is not yet signaling a buying opportunity. However, the downside to the $169.63 52-week low is roughly -22%, while the bull-case high target of $320 implies +47% upside, and the 12.95x forward PE, 0.52 PEG, and $773.53 million of trailing free cash flow suggest much of the bad news is priced in. The biggest downside risk is that forward EPS of $24.41 gets cut, which would make the stock look expensive rather than cheap. It is a reasonable buy only for patient, valuation-disciplined investors who can tolerate another 20% drawdown and are willing to wait for evidence that net customer additions have stabilized; momentum-oriented or risk-averse investors should wait for that confirmation.
HUBS is better suited to a long-term holding than a short-term trade. The company is in a growth-to-profitability transition with a 1.141 beta, a -65.57% max drawdown, and a 20% three-week swing from the October 23 high of $270.88 to $217.25, so short-term price action is dominated by sentiment and sector rotation rather than fundamentals. It pays no dividend (0% yield, 0% payout ratio), so there is no income component to support a short horizon, and earnings visibility is limited by decelerating customer growth and the unresolved AI-disruption question. A concrete suggested minimum holding period is 18–24 months, long enough to see whether net customer additions stabilize, whether the $24.41 forward EPS is delivered, and whether the multiple re-rates — while allowing the $767 million of Q2–Q3 buybacks and $773.53 million of trailing free cash flow to compound shareholder value.

